Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.

Reactive oxygen species in organ-specific autoimmunity. Auto Immun Highlights (2016) 0.75

Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology (1983) 40.64

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 25.66

Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36

Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology (1996) 10.26

Ferritin, iron homeostasis, and oxidative damage. Free Radic Biol Med (2002) 2.26

Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem Biophys Res Commun (2003) 2.15

Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol (1998) 1.97

Serum ferritin: Past, present and future. Biochim Biophys Acta (2010) 1.80

Onset of secondary progressive phase and long-term evolution of multiple sclerosis. J Neurol Neurosurg Psychiatry (2013) 1.69

Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med (1991) 1.28

Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity. J Neurol Sci (2008) 1.25

Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis. PLoS One (2013) 1.21

Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. Breast Cancer Res Treat (2011) 1.01

Isoforms of ferritin have a specific cellular distribution in the brain. J Neurosci Res (1994) 0.99

Oxidative stress in blood of HIV infected patients. Clin Chim Acta (1996) 0.99

Antioxidants and polyunsaturated fatty acids in multiple sclerosis. Eur J Clin Nutr (2005) 0.96

Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration. Mult Scler (2013) 0.96

Human serum albumin and its relation with oxidative stress. Clin Lab (2013) 0.96

Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients. Brain Res (1999) 0.96

Plasma lipid peroxidation and progression of disability in multiple sclerosis. Eur J Neurol (2007) 0.93

Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis. Oxid Med Cell Longev (2015) 0.92

Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity. Mult Scler (2005) 0.91

Oxidative stress in multiple sclerosis patients in clinical remission: association with the expanded disability status scale. J Neurol Sci (2012) 0.91

Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. J Neuroimmunol (2003) 0.86

Interferon-beta-1-b (IFN-B) decreases induced nitric oxide (NO) production by a human astrocytoma cell line. J Neuroimmunol (1998) 0.86

Relationship between iron metabolism, oxidative stress, and insulin resistance in patients with systemic lupus erythematosus. Scand J Rheumatol (2013) 0.82

Immunological and biochemical parameters of patients with metabolic syndrome and the participation of oxidative and nitroactive stress. Braz J Med Biol Res (2011) 0.82

Cerebrospinal fluid nitrate levels in patients with multiple sclerosis. Eur Neurol (1999) 0.78

News on multiple sclerosis: induction of immune tolerance, a biomarker for predicting disease activity, and CSF ferritin levels. J Neurol (2010) 0.77

Role of metabolic syndrome and antiretroviral therapy in adiponectin levels and oxidative stress in HIV-1 infected patients. Nutrition (2014) 0.80

Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation. Nutr Res (2015) 0.76

Metabolic syndrome increases oxidative stress but does not influence disability and short-time outcome in acute ischemic stroke patients. Metab Brain Dis (2015) 0.75

Disease progression and oxidative stress are associated with higher serum ferritin levels in patients with multiple sclerosis. J Neurol Sci (2016) 0.75

Increased lipid and protein oxidation and lowered anti-oxidant defenses in systemic lupus erythematosus are associated with severity of illness, autoimmunity, increased adhesion molecules, and Th1 and Th17 immune shift. Immunol Res (2017) 0.75